Abemaciclib and Letrozole in Patients With Estrogen Receptor-positive Rare Ovarian Cancer
Conditions
Low Grade Serous Ovarian Carcinoma · Adult Type Granulosa Cell Tumor
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
CHU de Liège, Liège, Liège, Belgium
Contact: Principal Investigator (Frédéric Kridelka, MD)UZ Gent, Ghent, Oost-Vlaanderen, Belgium
Contact: Principal Investigator (Hannelore Denys, MD PhD)UZ Leuven, Leuven, Vlaams-Brabant, Belgium
Contact: Study coordinator (Els Van Nieuwenhuysen, MD PhD) · els.vannieuwenhuysen@uzleuven.be · +3216342531Contact: Principal Investigator (Els Van Nieuwenhuysen, MD PhD)Institut De Cancerologie Strasbourg Europe, Strasbourg, Bas-Rhin, France
Contact: Principal Investigator (Lauriane Eberst, MD)Institut Bergonie, Bordeaux, Gironde, France
Contact: Principal Investigator (Coriolon Lebreton, MD)Institut Universitaire Du Cancer Toulouse-Oncopole, Toulouse, Haute-Garonne, France
Contact: Principal Investigator (Laurence Gladieff, MD)Institut De Cancerologie De L'Ouest, Saint-Herblain, Loire-Atlantique, France
Contact: Principal Investigator (Dominique Berton, MD)Centre Leon Berard, Lyon, Métropole de Lyon, France
Contact: Principal Investigator (Isabelle Ray-Coquard, MD PhD)Groupe Hospitalier Diaconesses Croix Saint Simon, Paris, Île-de-France Region, France
Contact: Principal Investigator (Frédéric Selle, MD)University Medical Center Groningen, Groningen, Provincie Groningen, Netherlands
Contact: Principal Investigator (Hilde Jalving, MD)Erasmus Medical Center Rotterdam, Rotterdam, South Holland, Netherlands
Contact: Principal Investigator (Ingrid Boere, MD)University Medical Center Utrecht, Utrecht, Utrecht, Netherlands
Contact: Principal Investigator (Inge Baas, MD)
Study leads
Els Van Nieuwenhuysen, MD PhD
Principal Investigator
UZ Leuven